Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Research and Development of Precision Immunology-Based Therapies	10.00M	5.00M	50.00M
Research and Development of Precision Immunology-Based Therapies Growth	100.00%	-90.00%	-
Total	10.00M	5.00M	50.00M
Total Growth	100.00%	-90.00%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
United States	10.00M	5.00M	50.00M
United States Growth	100.00%	-90.00%	-
Total	10.00M	5.00M	50.00M
Total Growth	100.00%	-90.00%	-

Source: S&P Global Market Intelligence.